Showing results (151-160 of 249) with videos related to
Sort By:
Pageof 25
Immunology|June 17, 2015
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimersGarry Dolton, Katie Tungatt, Angharad Lloyd, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenaseTrine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, et al.Seminars in Cancer Biology|April 3, 2002
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapyFrancisco Ruiz-Cabello, Teresa Cabrera, Miguel-Angel Lopez-Nevot, et al.Cancer Immunology, Immunotherapy : CII|July 27, 2012
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypesMonica Bernal, Francisco Ruiz-Cabello, Angel Concha, et al.Blood|November 23, 2006
RhoH is important for positive thymocyte selection and T-cell receptor signalingTatjana Dorn, Ursula Kuhn, Gerd Bungartz, et al.Vaccines|May 7, 2025
Vaccination Against RhoC in Prostate Cancer Patients Induces Potent and Long-Lasting CD4+ T Cell Responses with Cytolytic Potential in the Absence of Clinical Efficacy: A Randomized Phase II TrialSara Fresnillo Saló, Juliane Schuhmacher, Anne Rahbech, et al.Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.Cancer Immunology, Immunotherapy : CII|August 23, 2002
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21Isabel Maleno, Miguel Angel López-Nevot, Teresa Cabrera, et al.International Journal of Cancer|July 8, 2003
MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM componentsAngel Garcia-Lora, Marisol Martinez, Ignacio Algarra, et al.Journal of Medical Case Reports|April 22, 2008
Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case reportJose Manuel Cozar, Natalia Aptsiauri, Miguel Tallada, et al.Pageof 25